Latest Australian Markets News

Zoono Group has signed a five-year exclusive contract with Multisteps Pty Limited to apply its antimicrobial technology to fresh produce packaging in Australia, aiming to reduce food waste and boost sustainability.

Light & Wonder, Inc. transitions from an ASX Foreign Exempt Listing to a full ASX Listing, marking a significant regulatory shift without raising new capital. The company continues trading its shares as CHESS Depositary Interests on a 1, 1 basis.

Scentre Group reports a 3.1% rise in customer visits and a $29.5 billion sales tally across its Westfield centres, while confirming its 2025 earnings and distribution targets.

Associate Global Partners Limited (AGP) reported robust FY25 results, with funds under management climbing to $1.464 billion, driven by stellar investment returns and successful capital raisings. The firm is advancing its distribution reach and launching new products to sustain momentum.

MA Financial Group advances exclusive due diligence on a major Queensland retail asset and prepares a new ASX-listed credit notes offer, signaling strategic growth moves.

Light & Wonder, Inc. is set to extend its substantial share repurchase program to include its ASX-listed CHESS Depositary Interests starting November 7, 2025, coinciding with its planned Nasdaq delisting.

REA Group reported a solid start to FY26 with 4% revenue growth and a key acquisition that enhances its AI-driven property technology portfolio. Despite challenges in India, the Australian market’s strong yield growth and product adoption underpin a confident outlook.

Light & Wonder, Inc. posted robust Q3 2025 results, driven by strong gaming operations and record iGaming revenue, while advancing its transition to a sole ASX listing.

PEXA Group reported a robust first quarter for FY26, driven by refinancing growth in Australia and rising momentum in the UK market. The company reaffirmed its full-year guidance while advancing key strategic initiatives including platform modernization and a NatWest partnership.

Mad Paws Holdings Limited shares have been suspended from the ASX following court approval of its acquisition by Rover Group, Inc. This marks a significant milestone in the pet services sector consolidation.

Bioxyne Limited, through its subsidiary Breathe Life Sciences, has inked an exclusive deal to import, manufacture, and distribute Curaleaf’s Que Medical Inhalation Device in Australia, with a nationwide launch set for November 2025.

HALO Technologies reports a 17% rise in quarterly revenue, driven by a surge in brokerage income and a strategic launch of Managed Funds in Australia, supported by a recent $3.9 million rights issue.